JP2015521635A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521635A5
JP2015521635A5 JP2015518855A JP2015518855A JP2015521635A5 JP 2015521635 A5 JP2015521635 A5 JP 2015521635A5 JP 2015518855 A JP2015518855 A JP 2015518855A JP 2015518855 A JP2015518855 A JP 2015518855A JP 2015521635 A5 JP2015521635 A5 JP 2015521635A5
Authority
JP
Japan
Prior art keywords
solifenacin
compound
formula
salt
impurity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015518855A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015521635A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/002769 external-priority patent/WO2014005601A1/en
Publication of JP2015521635A publication Critical patent/JP2015521635A/ja
Publication of JP2015521635A5 publication Critical patent/JP2015521635A5/ja
Pending legal-status Critical Current

Links

JP2015518855A 2012-07-02 2012-07-02 ソリフェナシン又はその塩の調製方法 Pending JP2015521635A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/002769 WO2014005601A1 (en) 2012-07-02 2012-07-02 A process for the preparation of solifenacin or a salt thereof

Publications (2)

Publication Number Publication Date
JP2015521635A JP2015521635A (ja) 2015-07-30
JP2015521635A5 true JP2015521635A5 (enExample) 2015-09-10

Family

ID=46750264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015518855A Pending JP2015521635A (ja) 2012-07-02 2012-07-02 ソリフェナシン又はその塩の調製方法

Country Status (4)

Country Link
EP (1) EP2867210A1 (enExample)
JP (1) JP2015521635A (enExample)
CN (1) CN104411687A (enExample)
WO (1) WO2014005601A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104133011A (zh) * 2014-07-01 2014-11-05 北京万全德众医药生物技术有限公司 液相色谱法分离分析琥珀酸索利那新中间体及其有关物质
CN105348278B (zh) * 2014-11-14 2017-11-17 天津市医药集团技术发展有限公司 一种琥珀酸索利那新杂质的制备方法
CN105566315B (zh) * 2016-01-20 2017-07-18 成都华宇制药有限公司 一种索利那新的后处理及制备琥珀酸索利那新的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
AUPP405098A0 (en) * 1998-06-12 1998-07-02 Access Pharmaceuticals Australia Pty Limited Novel methods of preparation of vitamin b12 derivatives suitable for conjugation to pharmaceuticals
ME01059B (me) * 2003-12-23 2012-10-20 Janssen Sciences Ireland Uc Proces za pripremanje (3r,3as,6ar)-heksahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (izobutil) amino]-1-benzil-2- hidroksipropilkarbamata
JPWO2005087231A1 (ja) 2004-03-16 2008-01-24 アステラス製薬株式会社 ソリフェナシン含有組成物
CN1934109B (zh) * 2004-03-25 2010-06-23 安斯泰来制药株式会社 用于固体制剂的索非那新或其盐的组合物
EP1879867A2 (en) 2005-12-21 2008-01-23 Teva Pharmaceutical Industries Ltd Intermediates for preparing solifenacin
CZ300699B6 (cs) * 2006-06-21 2009-07-22 Zentiva, A. S. Zpusob prípravy solifenacinu
CN101711248A (zh) 2007-03-30 2010-05-19 医药化学公司 一种改进的素非那新合成工艺
ITMI20080195A1 (it) * 2008-02-08 2009-08-09 Dipharma Francis Srl Procedimento per la preparazione di solifenacin
US8283470B2 (en) 2009-03-09 2012-10-09 Megafine Pharma(P) Ltd. Method for the preparation of solifenacin and intermediate thereof

Similar Documents

Publication Publication Date Title
JP6594487B2 (ja) 抗ウイルス化合物の合成
JP5567557B2 (ja) テトラヒドロイソキノリンの製造方法
JP2018511634A5 (enExample)
JP2015536940A (ja) 抗ウイルス性ホスホネート類似体及びその製造方法
JP2019524883A5 (enExample)
JP2014503574A5 (enExample)
JP2016512824A5 (enExample)
JP2012500277A5 (enExample)
JP2018510184A5 (enExample)
JP2005534713A (ja) ジヒドロピラゾロピリジン化合物
CN107531682A (zh) B‑raf激酶抑制剂的马来酸盐、其结晶形式、制备方法和用途
WO2014168103A1 (ja) ピロール誘導体の結晶及びその製造方法
JP2014510746A5 (enExample)
JP2004523573A (ja) キノリルプロピルピペリジン誘導体、その製造およびそれを含む組成物
CN105849108A (zh) 磷脂酰肌醇3-激酶抑制剂的制备方法
JP7778750B2 (ja) 3-(5-フルオロベンゾフラン-3-イル)-4-(5-メチル-5H-[1,3]ジオキソロ[4,5-f]インドール-7-イル)ピロール-2,5-ジオンの固体形態
KR20170068596A (ko) 트리시클릭 회전장애이성질체 화합물
JP2015521635A5 (enExample)
WO2015138933A1 (en) Solid state forms of dolutegravir sodium
US20080091023A1 (en) Processes for optical resolution of 1-phenyl-1,2,3,4-tetrahydroisoquinoline
JP4450628B2 (ja) ファルネシルトランスフェラーゼインヒビターとして使用するためのベンジルイミダゾリル置換2−キノリンおよびキナゾリン誘導体
CA2712141A1 (en) Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers
KR20140003497A (ko) 바이사이클릭 벤젠 유도체로 치환된 신규 항진균성 5,6-디하이드로-4H-피롤로[1,2-a][1,4]벤조디아제핀 및 6H-피롤로[1,2-a][1,4]벤조디아제핀
JP2011522849A5 (enExample)
RU2014145806A (ru) Способы производства (3,4-дихлорфенил)-((s)-3-пропил-пирролидин-3-ил)-метанонгидрохлорида